- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Book
- May 2021
- 640 Pages
- Book
- July 2020
- 464 Pages
The Cardiac Pacing market is a subset of the Cardiology field that focuses on the use of electrical stimulation to treat heart rhythm disorders. This includes the use of pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These devices are used to treat bradycardia, tachycardia, and other arrhythmias. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments.
The Cardiac Pacing market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more